Re. FDA, maybe as the first trials are in Aus, we don't need FDA approval? Jump on the webinar and ask Bob
Re. Why the buying? Maybe because we now have a roadmap into the first in-human trials? The market cap is tiny even now, for the potential the company has. Not too late to buy in buddy.
